title: Celgene shells out for antisense drug.
authors.forename: Mark
authors.initials: M
authors.lastname: Ratner
mesh_terms: D017322:Clinical Trials, Phase II as Topic; D003424:Crohn Disease / Q000191:economics* / Q000628:therapy*; D016373:DNA, Antisense / Q000235:genetics* / Q000627:therapeutic use*; D004345:Drug Industry / Q000191:economics*; D015316:Genetic Therapy / Q000191:economics*; D006801:Humans; D014481:United States
chemical_list: D016373:DNA, Antisense